Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts
R
R
Kleiverda
G
G
Gemzell
K
K
Davies
S
S
Jelinska
K
K
D000021:Abortifacient Agents, Steroidal / Q000600:supply & distribution*; D000028:Abortion, Induced / Q000379:methods*; D005260:Female; D006297:Health Services Accessibility / Q000592:standards; D006801:Humans; D015735:Mifepristone / Q000600:supply & distribution*; D016595:Misoprostol / Q000600:supply & distribution*; D011247:Pregnancy; D017216:Telemedicine / Q000706:statistics & numerical data*
D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone